海南海药：注射用美罗培南通过仿制药一致性评价

Core Viewpoint - Hainan Haiyao's subsidiary has received approval for a new injectable antibiotic, Meropenem, which has passed the consistency evaluation for generic drug quality and efficacy [1] Group 1: Company Developments - Hainan Haiyao's wholly-owned subsidiary, Haikou Pharmaceutical Factory Co., Ltd., has recently obtained the approval notice for the supplemental application of injectable Meropenem from the National Medical Products Administration [1] - The approved drug is indicated for infections caused by single or multiple bacteria sensitive to Meropenem in both adults and children [1]